{"id":9227,"date":"2024-08-05T21:20:22","date_gmt":"2024-08-05T21:20:22","guid":{"rendered":"https:\/\/medipharmsolutions.com\/?p=9227"},"modified":"2024-08-05T21:20:24","modified_gmt":"2024-08-05T21:20:24","slug":"how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach","status":"publish","type":"post","link":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/","title":{"rendered":"How does Pharmacovigilance Practices vary with biologics? – A Patient Centric approach"},"content":{"rendered":"\n<p>1. Complexity of Biopharmaceutical Products:<\/p>\n\n\n\n<p> - Biological Variability: Biopharmaceuticals, derived from living organisms, exhibit greater variability compared to small-molecule drugs, complicating safety assessments.<\/p>\n\n\n\n<p> - Manufacturing Changes: Minor changes in manufacturing processes can impact the safety and efficacy of biopharmaceuticals, requiring robust monitoring.<\/p>\n\n\n\n<p>2. Immunogenicity:<\/p>\n\n\n\n<p> - Immune Responses: Biopharmaceuticals can induce immune responses, including the production of anti-drug antibodies, which can affect drug efficacy and safety.<\/p>\n\n\n\n<p> - Detection and Management: Identifying and managing immunogenicity-related adverse events pose significant challenges.<\/p>\n\n\n\n<p>3. Complex Adverse Event Profiles:<\/p>\n\n\n\n<p> - Multifaceted Adverse Events: Biopharmaceuticals often have complex adverse event profiles, including delayed or chronic effects, making detection and assessment challenging.<\/p>\n\n\n\n<p> - Rare and Long-Term Effects: Detecting rare and long-term adverse events requires extensive post-marketing surveillance.<\/p>\n\n\n\n<p>4. Regulatory and Compliance Issues:<\/p>\n\n\n\n<p> - Diverse Regulations: Different countries have varying pharmacovigilance regulations, making global compliance challenging for biopharmaceutical companies.<\/p>\n\n\n\n<p> - Stringent Requirements: Regulatory bodies impose stringent reporting requirements and expect comprehensive safety data, adding to the workload.<\/p>\n\n\n\n<p>5. Data Management:<\/p>\n\n\n\n<p> - Data Volume and Quality: The sheer volume of safety data from various sources (clinical trials, real-world evidence, spontaneous reports) needs effective management and quality control.<\/p>\n\n\n\n<p> - Integration of Data Sources: Integrating data from different sources and formats for comprehensive safety assessments is complex.<\/p>\n\n\n\n<p>6. Technological and Analytical Challenges:<\/p>\n\n\n\n<p> - Advanced Analytics: Utilizing advanced analytical methods, such as machine learning and AI, to detect and predict adverse events requires specialized expertise and technology.<\/p>\n\n\n\n<p> - Signal Detection: Identifying true safety signals from large datasets while minimizing false positives is challenging.<\/p>\n\n\n\n<p> Best Practices in Pharmacovigilance for Biopharmaceuticals<\/p>\n\n\n\n<p>1. Robust Risk Management Plans:<\/p>\n\n\n\n<p> - Comprehensive Planning: Develop detailed risk management plans (RMPs) that outline potential risks, monitoring strategies, and mitigation measures.<\/p>\n\n\n\n<p> - Proactive Measures: Implement proactive risk minimization strategies, such as patient education and healthcare provider training.<\/p>\n\n\n\n<p>2. Advanced Immunogenicity Assessment:<\/p>\n\n\n\n<p> - Early Detection: Utilize advanced methods to detect and characterize immunogenicity early in the drug development process.<\/p>\n\n\n\n<p> - Ongoing Monitoring: Continuously monitor for immunogenicity throughout the product lifecycle and adapt risk management strategies accordingly.<\/p>\n\n\n\n<p>3. Enhanced Data Collection and Integration:<\/p>\n\n\n\n<p> - Real-World Evidence: Leverage real-world evidence from electronic health records, patient registries, and other sources to complement clinical trial data.<\/p>\n\n\n\n<p> - Harmonized Databases: Develop harmonized databases and data standards to facilitate integration and analysis of safety data.<\/p>\n\n\n\n<p>4. Utilization of Advanced Analytics:<\/p>\n\n\n\n<p> - Machine Learning and AI: Apply machine learning and AI techniques to enhance signal detection, data mining, and predictive modeling.<\/p>\n\n\n\n<p> - Data Visualization: Use advanced data visualization tools to identify trends and patterns in safety data.<\/p>\n\n\n\n<p>5. Global Regulatory Compliance:<\/p>\n\n\n\n<p> - Harmonized Approach: Adopt a harmonized approach to meet diverse regulatory requirements across different regions.<\/p>\n\n\n\n<p> - Regular Updates: Stay updated with evolving regulatory guidelines and ensure timely compliance.<\/p>\n\n\n\n<p>6. Effective Communication and Training:<\/p>\n\n\n\n<p> - Stakeholder Communication: Maintain clear and transparent communication with all stakeholders, including regulatory bodies, healthcare providers, and patients.<\/p>\n\n\n\n<p> - Ongoing Training: Provide ongoing training to pharmacovigilance teams on the latest best practices, regulatory requirements, and technological advancements.<\/p>\n\n\n\n<p>7. Collaborative Efforts:<\/p>\n\n\n\n<p> - Industry Collaboration: Collaborate with other biopharmaceutical companies, regulatory agencies, and academic institutions to share data and best practices.<\/p>\n\n\n\n<p> - Public-Private Partnerships: Engage in public-private partnerships to enhance pharmacovigilance capabilities and infrastructure.<\/p>\n\n\n\n<p>8. Patient-Centric Approach:<\/p>\n\n\n\n<p> - Patient Involvement: Involve patients in pharmacovigilance activities, such as reporting adverse events and providing feedback on risk management measures.<\/p>\n\n\n\n<p> - Patient Safety: Prioritize patient safety by ensuring timely identification, assessment, and communication of risks.<\/p>\n\n\n\n<p>By addressing these challenges and implementing best practices, biopharmaceutical companies can enhance the safety monitoring and management of their products, ensuring better patient outcomes and regulatory compliance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>1. Complexity of Biopharmaceutical Products: – Biological Variability: Biopharmaceuticals, derived from living organisms, exhibit greater variability compared to small-molecule drugs, complicating safety assessments. – Manufacturing Changes: Minor changes in manufacturing processes can impact the safety and efficacy of biopharmaceuticals, requiring robust monitoring. 2. Immunogenicity: – Immune Responses: Biopharmaceuticals can induce immune responses, including the production […]<\/p>\n","protected":false},"author":3,"featured_media":9228,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[115],"tags":[],"class_list":["post-9227","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-drug-safety"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.5 (Yoast SEO v22.7) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>How does Pharmacovigilance Practices vary with biologics? - A Patient Centric approach - Drug Safety and Pharmacovigilance Course<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How does Pharmacovigilance Practices vary with biologics? - A Patient Centric approach\" \/>\n<meta property=\"og:description\" content=\"1. Complexity of Biopharmaceutical Products: - Biological Variability: Biopharmaceuticals, derived from living organisms, exhibit greater variability compared to small-molecule drugs, complicating safety assessments. - Manufacturing Changes: Minor changes in manufacturing processes can impact the safety and efficacy of biopharmaceuticals, requiring robust monitoring. 2. Immunogenicity: - Immune Responses: Biopharmaceuticals can induce immune responses, including the production […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/\" \/>\n<meta property=\"og:site_name\" content=\"Drug Safety and Pharmacovigilance Course\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Medipharmsolutions\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-05T21:20:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-05T21:20:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2024\/08\/AdobeStock_506834579.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"770\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"medipharmsolutions\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Medipharmsolut2\" \/>\n<meta name=\"twitter:site\" content=\"@Medipharmsolut2\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"medipharmsolutions\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/\"},\"author\":{\"name\":\"medipharmsolutions\",\"@id\":\"https:\/\/medipharmsolutions.com\/#\/schema\/person\/4b0e43338609298fc67acccf1e617933\"},\"headline\":\"How does Pharmacovigilance Practices vary with biologics? – A Patient Centric approach\",\"datePublished\":\"2024-08-05T21:20:22+00:00\",\"dateModified\":\"2024-08-05T21:20:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/\"},\"wordCount\":674,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/medipharmsolutions.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2024\/08\/AdobeStock_506834579.jpeg\",\"articleSection\":[\"Drug Safety\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/\",\"url\":\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/\",\"name\":\"How does Pharmacovigilance Practices vary with biologics? - A Patient Centric approach - Drug Safety and Pharmacovigilance Course\",\"isPartOf\":{\"@id\":\"https:\/\/medipharmsolutions.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2024\/08\/AdobeStock_506834579.jpeg\",\"datePublished\":\"2024-08-05T21:20:22+00:00\",\"dateModified\":\"2024-08-05T21:20:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#primaryimage\",\"url\":\"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2024\/08\/AdobeStock_506834579.jpeg\",\"contentUrl\":\"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2024\/08\/AdobeStock_506834579.jpeg\",\"width\":770,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medipharmsolutions.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How does Pharmacovigilance Practices vary with biologics? – A Patient Centric approach\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medipharmsolutions.com\/#website\",\"url\":\"https:\/\/medipharmsolutions.com\/\",\"name\":\"Drug Safety and Pharmacovigilance Course\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/medipharmsolutions.com\/#organization\"},\"alternateName\":\"Drug Safety and Pharmacovigilance Course\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medipharmsolutions.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/medipharmsolutions.com\/#organization\",\"name\":\"Drug Safety and Pharmacovigilance Course\",\"alternateName\":\"Drug Safety and Pharmacovigilance Course\",\"url\":\"https:\/\/medipharmsolutions.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medipharmsolutions.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2023\/11\/medipharm-logowebsite-backgroundwhite.jpg\",\"contentUrl\":\"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2023\/11\/medipharm-logowebsite-backgroundwhite.jpg\",\"width\":70,\"height\":83,\"caption\":\"Drug Safety and Pharmacovigilance Course\"},\"image\":{\"@id\":\"https:\/\/medipharmsolutions.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Medipharmsolutions\",\"https:\/\/x.com\/Medipharmsolut2\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/medipharmsolutions.com\/#\/schema\/person\/4b0e43338609298fc67acccf1e617933\",\"name\":\"medipharmsolutions\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medipharmsolutions.com\/#\/schema\/person\/image\/\",\"url\":\"\/\/www.gravatar.com\/avatar\/eb1878a2e4ff67b36af415de3ceefd31?s=96&r=g&d=mm\",\"contentUrl\":\"\/\/www.gravatar.com\/avatar\/eb1878a2e4ff67b36af415de3ceefd31?s=96&r=g&d=mm\",\"caption\":\"medipharmsolutions\"},\"url\":\"https:\/\/medipharmsolutions.com\/blog\/author\/medipharmsolutions\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How does Pharmacovigilance Practices vary with biologics? - A Patient Centric approach - Drug Safety and Pharmacovigilance Course","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/","og_locale":"en_US","og_type":"article","og_title":"How does Pharmacovigilance Practices vary with biologics? - A Patient Centric approach","og_description":"1. Complexity of Biopharmaceutical Products: - Biological Variability: Biopharmaceuticals, derived from living organisms, exhibit greater variability compared to small-molecule drugs, complicating safety assessments. - Manufacturing Changes: Minor changes in manufacturing processes can impact the safety and efficacy of biopharmaceuticals, requiring robust monitoring. 2. Immunogenicity: - Immune Responses: Biopharmaceuticals can induce immune responses, including the production […]","og_url":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/","og_site_name":"Drug Safety and Pharmacovigilance Course","article_publisher":"https:\/\/www.facebook.com\/Medipharmsolutions","article_published_time":"2024-08-05T21:20:22+00:00","article_modified_time":"2024-08-05T21:20:24+00:00","og_image":[{"width":770,"height":500,"url":"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2024\/08\/AdobeStock_506834579.jpeg","type":"image\/jpeg"}],"author":"medipharmsolutions","twitter_card":"summary_large_image","twitter_creator":"@Medipharmsolut2","twitter_site":"@Medipharmsolut2","twitter_misc":{"Written by":"medipharmsolutions","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#article","isPartOf":{"@id":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/"},"author":{"name":"medipharmsolutions","@id":"https:\/\/medipharmsolutions.com\/#\/schema\/person\/4b0e43338609298fc67acccf1e617933"},"headline":"How does Pharmacovigilance Practices vary with biologics? – A Patient Centric approach","datePublished":"2024-08-05T21:20:22+00:00","dateModified":"2024-08-05T21:20:24+00:00","mainEntityOfPage":{"@id":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/"},"wordCount":674,"commentCount":0,"publisher":{"@id":"https:\/\/medipharmsolutions.com\/#organization"},"image":{"@id":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#primaryimage"},"thumbnailUrl":"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2024\/08\/AdobeStock_506834579.jpeg","articleSection":["Drug Safety"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/","url":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/","name":"How does Pharmacovigilance Practices vary with biologics? - A Patient Centric approach - Drug Safety and Pharmacovigilance Course","isPartOf":{"@id":"https:\/\/medipharmsolutions.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#primaryimage"},"image":{"@id":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#primaryimage"},"thumbnailUrl":"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2024\/08\/AdobeStock_506834579.jpeg","datePublished":"2024-08-05T21:20:22+00:00","dateModified":"2024-08-05T21:20:24+00:00","breadcrumb":{"@id":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#primaryimage","url":"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2024\/08\/AdobeStock_506834579.jpeg","contentUrl":"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2024\/08\/AdobeStock_506834579.jpeg","width":770,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/medipharmsolutions.com\/blog\/how-does-pharmacovigilance-practices-vary-with-biologics-a-patient-centric-approach\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medipharmsolutions.com\/"},{"@type":"ListItem","position":2,"name":"How does Pharmacovigilance Practices vary with biologics? – A Patient Centric approach"}]},{"@type":"WebSite","@id":"https:\/\/medipharmsolutions.com\/#website","url":"https:\/\/medipharmsolutions.com\/","name":"Drug Safety and Pharmacovigilance Course","description":"","publisher":{"@id":"https:\/\/medipharmsolutions.com\/#organization"},"alternateName":"Drug Safety and Pharmacovigilance Course","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medipharmsolutions.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/medipharmsolutions.com\/#organization","name":"Drug Safety and Pharmacovigilance Course","alternateName":"Drug Safety and Pharmacovigilance Course","url":"https:\/\/medipharmsolutions.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medipharmsolutions.com\/#\/schema\/logo\/image\/","url":"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2023\/11\/medipharm-logowebsite-backgroundwhite.jpg","contentUrl":"https:\/\/medipharmsolutions.com\/wp-content\/uploads\/2023\/11\/medipharm-logowebsite-backgroundwhite.jpg","width":70,"height":83,"caption":"Drug Safety and Pharmacovigilance Course"},"image":{"@id":"https:\/\/medipharmsolutions.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Medipharmsolutions","https:\/\/x.com\/Medipharmsolut2"]},{"@type":"Person","@id":"https:\/\/medipharmsolutions.com\/#\/schema\/person\/4b0e43338609298fc67acccf1e617933","name":"medipharmsolutions","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medipharmsolutions.com\/#\/schema\/person\/image\/","url":"\/\/www.gravatar.com\/avatar\/eb1878a2e4ff67b36af415de3ceefd31?s=96&r=g&d=mm","contentUrl":"\/\/www.gravatar.com\/avatar\/eb1878a2e4ff67b36af415de3ceefd31?s=96&r=g&d=mm","caption":"medipharmsolutions"},"url":"https:\/\/medipharmsolutions.com\/blog\/author\/medipharmsolutions\/"}]}},"_links":{"self":[{"href":"https:\/\/medipharmsolutions.com\/wp-json\/wp\/v2\/posts\/9227","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medipharmsolutions.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medipharmsolutions.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medipharmsolutions.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/medipharmsolutions.com\/wp-json\/wp\/v2\/comments?post=9227"}],"version-history":[{"count":1,"href":"https:\/\/medipharmsolutions.com\/wp-json\/wp\/v2\/posts\/9227\/revisions"}],"predecessor-version":[{"id":9229,"href":"https:\/\/medipharmsolutions.com\/wp-json\/wp\/v2\/posts\/9227\/revisions\/9229"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medipharmsolutions.com\/wp-json\/wp\/v2\/media\/9228"}],"wp:attachment":[{"href":"https:\/\/medipharmsolutions.com\/wp-json\/wp\/v2\/media?parent=9227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medipharmsolutions.com\/wp-json\/wp\/v2\/categories?post=9227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medipharmsolutions.com\/wp-json\/wp\/v2\/tags?post=9227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}